Home > Compound List > Product Information
Salsalate_Molecular_structure_CAS_552-94-3)
Click picture or here to close

Salsalate

Catalog No. SML0070 Name Sigma Aldrich
CAS Number 552-94-3 Website http://www.sigmaaldrich.com
M. F. C14H10O5 Telephone 1-800-521-8956
M. W. 258.2262 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 1210

SYNONYMS

IUPAC name
2-(2-hydroxybenzoyloxy)benzoic acid
IUPAC Traditional name
salina
Synonyms
2-Hydroxybenzoic acid 2-carboxyphenyl ester
disalicylic acid
salicyloxysalicylic acid
2-(2-Hydroxybenzoyl)oxybenzoic acid
salicylsalicylic acid

DATABASE IDS

MDL Number MFCD00020252
CAS Number 552-94-3
EC Number 209-027-4

PROPERTIES

Empirical Formula (Hill Notation) C14H10O5
Purity ≥98% (HPLC)
Apperance white to tan powder
Solubility DMSO: ≥15 mg/mL
GHS Pictograms GHS07
GHS Pictograms GHS09
GHS Signal Word Warning
GHS Hazard statements H302-H400
European Hazard Symbols Harmful Harmful (Xn)
European Hazard Symbols Nature polluting Nature polluting (N)
MSDS Link Download
GHS Precautionary statements P273
Risk Statements 22-50
Safety Statements 61
Storage Temperature room temp
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Salsalate is a nonsteroidal anti-inflammatory drug (NSAID), a nonacetylated salicylate with no more problems of gastrointestinal bleeding than placebo. It inhibits synthesis and release of prostaglandins through the inactivation of cyclooxygenase-1 (COX-1) and COX-2. Salsalate is currently being investigated as a treatment for Type 2 diabetes with possible use to prevent the disease in people at risk. It reduces blood glucose concentrations in patients with type 2 diabetes, as well as in insulin-resistant patients without diabetes.
Description (简体中文)
Biochem/physiol Actions
Salsalate is a nonsteroidal anti-inflammatory drug (NSAID), a nonacetylated salicylate with no more problems of gastrointestinal bleeding than placebo. It inhibits synthesis and release of prostaglandins through the inactivation of cyclooxygenase-1 (COX-1) and COX-2. Salsalate is currently being investigated as a treatment for Type 2 diabetes with possible use to prevent the disease in people at risk. It reduces blood glucose concentrations in patients with type 2 diabetes, as well as in insulin-resistant patients without diabetes.

REFERENCES